fbpx

PSA announce intent to acquire Australasian College of Pharmacy

28 January 2025

 

The Pharmaceutical Society of Australia (PSA) Board has today announced plans to acquire the Australasian College of Pharmacy, further growing PSA’s leadership in education and training for pharmacists, pharmacy assistants, and technicians.

 

The Australasian College of Pharmacy (the College) is a member-based organisation developing and delivering education, training, and research programs to pharmacists and pharmacy assistants since 1976.

 

The decision to acquire the College is part of the PSA Board’s broader plan to maximise member value through growth, expanding education opportunities for the profession, and securing a long-term, sustainable future for PSA as the premier training and education provider for pharmacists, pharmacy assistants and technicians.

 

PSA’s acquisition of the College builds on its long history of high-quality, nation-leading education and training for pharmacists, allowing further investment in professional and practice support for members.

 

The PSA Board has carefully considered the impact of acquiring the College, and alongside independent advice from third-party experts the Board is confident this is the right path forward for PSA, its members, and the broader profession.

 

National President and Chair of the PSA Board Associate Professor Fei Sim FPS said the acquisition will be a transformational opportunity to grow PSA’s industry-leading education and workforce development offer.

 

“The PSA Board’s strategic decision to acquire the Australasian College of Pharmacy secures a long-term future for pharmacy workforce education. It puts PSA in a stronger representative and financial position to support and advocate for our members during this pivotal time of practice change in pharmacy,” Associate Professor Sim said.

 

“Along with the PSA Board, I fully understand the challenges pharmacists are facing, as we transition to full scope of practice and our roles become increasingly demanding.

Growing our footprint within pharmacy education means we can further invest in not only education, but also the professional and practice support PSA provides. As our profession continues to mature, this unity will provide the necessary strength our profession needs at this critical time of change to fully utilise our skills and expertise.

 

“We are ambitious about our future growth as an organisation, as the peak education and representative body for all pharmacists across all areas of practice.

 

“We look forward to being able to provide even more education opportunities and support to pharmacists, pharmacy assistants and technicians, strengthening our pharmacy profession and ultimately improving care for our patients,” Associate Professor Sim concluded.

 

ACP Chief Executive Officer Amanda Seeto said the College and the PSA had always shared a commitment to providing contemporary education and training in a format that is accessible, efficient, and most importantly – highly relevant to Australian pharmacists.

 

“This exciting and pragmatic change maximises the focus on world-leading professional development for Australian pharmacists, no matter their practice setting or career stage.

 

“The move will set our sector up for success, at a time when pharmacy is becoming an increasingly valued frontline health service.”

 

PSA members are set to vote on matters relating to the acquisition at an upcoming meeting.

 

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

Next generation of early career pharmacy leaders announced

12 October 2023

 

The Pharmaceutical Society of Australia (PSA) has appointed ten early career pharmacists from around Australia to lead the ECP Community of Specialty Interest (CSI), and support ECP Board Director Ayomide Ogundipe MPS as CSI Chair.

The ECP Community of Specialty Interest will be led by:

  • Ayomide Ogundipe MPS (Chair)
  • Abby Richardson MPS
  • Elissar Mansour MPS
  • Erin Cooper MPS
  • Jala Moushi MPS
  • James Buckley MPS
  • Keiran Batavia MPS
  • Monique Licht MPS
  • Raymond Truong MPS
  • Shaylee Mills MPS

 

ECP Board Director and Community of Specialty Interest Chair Ayomide Ogundipe MPS celebrated the diverse range of skills and experience each leader brings to the team.

“Working closely with the CSI leadership team, we are continuing to build and foster peer support through mentoring, engagement with ECPs across all states and territories and policy and advocacy,” Ms Ogundipe said.

“Our profession is seeing a paradigm shift in practice and scope, and it is so important that ECPs are part of these discussions moving forward to bring their diverse insights and experiences to the table.

“Through the CSI Early Career Pharmacists have a direct avenue to actively engage with PSA and the broader profession. I encourage all pharmacists in the early stages of their careers to get involved and join the CSI.”

PSA Chief Executive Officer A/Prof Steve Morris also welcomed the ECP leadership team.

“The ECP Community of Specialty Interest offers pharmacists in the early stages of their careers the opportunity to connect with their colleagues and shape the direction of our profession,” A/Prof Morris said.

“PSA proudly supports early career pharmacists to get the most out of their careers, from their registration to retirement.

“I am looking forward to continuing our work with Ayomide and her team to ensure that PSA is best supporting pharmacists at all stages of their careers.”

The Early Career Pharmacist – Community of Specialty Interest is an exclusive forum for PSA members. Join PSA today by visiting www.psa.org.au/membership

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au